Adverse effects of high-dose interferon-α-2a treatment for chronic hepatitis B
✍ Scribed by Elif Doyuk Kartal; Saygin Nayman Alpat; Ilhan Ozgunes; Gaye Usluer
- Book ID
- 105639221
- Publisher
- Springer Healthcare Communications
- Year
- 2007
- Tongue
- English
- Weight
- 253 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0741-238X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Treatment of chronic hepatitis C with Interferon (IFN) ␣2b monotherapy results in 10% to 15% sustained virological response (SVR). Combining IFN with ribavirin increases this response. In this analysis, using the Markov model, 6 treatment strategies for chronic hepatitis C (previously untreated
Chronic hepatitis C is often a progressive liver disease for which there is no satisfactory treatment. We studied the efficacy of recombinant a-interferon or y-interferon in the treatment of this disease in comparison with a control group. Thirty patients were randomly assigned to three groups. Ten
Recombinant human a-interferon is now under intensive investigation as therapy for chronic Type B hepatitis. Recent reports have suggested that prolonged a- interferon therapy may induce autoimmune reactions. We have evaluated the problem of autoimmunity related to a-interferon therapy by testing fo